Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextrose prolotherapy versus methylprednisolone injection for carpal tunnel syndrome
IRCT20180416039323N3Phase 2Completed
- Sponsor
- Aja University of Medical Sciences
- Start
- Dec 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dextrose, methylprednisolone and lidocaine in carpal tunnel syndrome (CTS) (2 arms), sponsored by Aja University of Medical Sciences. Primary endpoints: Boston questionnaire performance assessment, Pain intensity and 1 more. Started Dec 2021; status: completed.
02
Drugs
dextrosemethylprednisolonelidocaine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on IRCT20180416039323N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180416039323N3.